Document is current
Any future updates will be listed below
-
Authors
Moore, Avalon S. https://orcid.org/0000-0002-8109-6723
Vitu, Bridget
Fraizer-Bisner, Felicia
Williams, Peter J.
van der Merwe, Lucy
Gouda, Abdelrhman
Kirilova, Dessislava
Pittenger, Christopher https://orcid.org/0000-0003-2117-9321
Pushkarskaya, Helen
- License Information
-
More Information
Article History
Received: 29 July 2025
Accepted: 25 February 2026
First Online: 20 March 2026
Competing interests
: Chris Pittenger has consulted in the past 12 months for Freedom Biosciences and Biohaven Pharmaceuticals. He receives research support from Freedom Biosciences, Transcend Therapeutics, and Biohaven Pharmaceuticals. He holds equity in Alco Therapeutics, Lucid.Care, and Mind Therapeutics. He has patents pending on various therapeutic psychedelics and combinations, and the identification of antibodies involved in rapid-onset autoimmune neuropsychiatric disorders, none of which are relevant to the current work. He receives royalties from Oxford University Press and UpToDate. Other authors declare no competing interests.
